EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,840,500 | +14.3% | 130,000 | 0.0% | 0.54% | +18.6% |
| Q2 2023 | $2,484,300 | -17.4% | 130,000 | -16.1% | 0.46% | -3.2% |
| Q1 2023 | $3,008,550 | +21.0% | 155,000 | 0.0% | 0.47% | +16.5% |
| Q4 2022 | $2,486,200 | +2.3% | 155,000 | 0.0% | 0.40% | -3.3% |
| Q3 2022 | $2,430,000 | +349.2% | 155,000 | +496.2% | 0.42% | +350.5% |
| Q2 2022 | $541,000 | -8.1% | 26,000 | 0.0% | 0.09% | -18.4% |
| Q1 2022 | $589,000 | +3.9% | 26,000 | -16.1% | 0.11% | -8.1% |
| Q4 2021 | $567,000 | -13.4% | 31,000 | 0.0% | 0.12% | -13.9% |
| Q3 2021 | $655,000 | -42.0% | 31,000 | -50.0% | 0.14% | -38.5% |
| Q2 2021 | $1,130,000 | -45.9% | 62,000 | -33.0% | 0.23% | -45.6% |
| Q1 2021 | $2,090,000 | +1.6% | 92,500 | -9.8% | 0.43% | -20.2% |
| Q4 2020 | $2,057,000 | +10.0% | 102,500 | +34.0% | 0.54% | +8.9% |
| Q3 2020 | $1,870,000 | +3.0% | 76,500 | 0.0% | 0.50% | +6.9% |
| Q2 2020 | $1,816,000 | -17.0% | 76,500 | -39.8% | 0.46% | -21.5% |
| Q1 2020 | $2,187,000 | +21.7% | 127,000 | +24.5% | 0.59% | +3.1% |
| Q4 2019 | $1,797,000 | -0.4% | 102,000 | 0.0% | 0.57% | +11.9% |
| Q3 2019 | $1,804,000 | – | 102,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |